{
    "Title": "Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG)",
    "URL": "https://doi.org/10.1371/journal.pntd.0012035",
    "Published": "March 14, 2024",
    "Subject_Areas": [
        "Enzyme-linked immunoassays",
        "Antibodies",
        "B cells",
        "Babesia",
        "Babesiosis",
        "Antibody therapy",
        "Atovaquone",
        "Blood plasma"
    ],
    "Authors": {
        "Julia Kostka": [
            "Infectious Disease, UConn Health, Farmington, Connecticut, United States of America"
        ],
        "Anu S. Maharjan": [
            "Pathology and Laboratory Medicine, UConn Health, Farmington, Connecticut, United States of America"
        ],
        "Sanjai Kumar": [
            "Food and Drug Administration, Silver Spring, Maryland, United States of America"
        ],
        "Douglas Hackenyos": [
            "Pharmacy, UConn Health, Farmington, Connecticut, United States of America"
        ],
        "Peter J. Krause": [
            "Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, United States of America"
        ],
        "Kevin Dieckhaus": [
            "Infectious Disease, UConn Health, Farmington, Connecticut, United States of America"
        ]
    }
}